Microfluidic Point-of-Care Ecarin-Based Clotting and Chromogenic Assays for Monitoring Direct Thrombin Inhibitors.
Direct thrombin inhibitors (DTIs), such as bivalirudin and dabigatran, have maintained steady inpatient and outpatient use as substitutes for heparin and warfarin, respectively, because of their high bioavailability and relatively safe "ontherapy" range. Current clinical methods lack the capacity to...
| Published in: | Journal of Extra-Corporeal Technology Vol. 51; no. 1; pp. 29 - 38 |
|---|---|
| Main Authors: | , , , , |
| Format: | Journal Article |
| Published: |
AMSECT
Mar2019
|
| Online Access: | View this record in EBSCOhost |